Real-world efficacy and tolerability of fremanezumab in adults with chronic migraine: a 3-month, single-center, prospective, observational study by Christopher Kjaer Cullum, Christopher Kjaer Cullum, Basit Ali Chaudhry, Basit Ali Chaudhry, Thien Phu Do, Thien Phu Do, Thien Phu Do, Faisal Mohammad Amin, Faisal Mohammad Amin, Faisal Mohammad Amin

Get full text

Average steps per day as marker of treatment response with anti-CGRP mAbs in adults with chronic migraine: a pilot study by Frederik Thal Jantzen, Basit Ali Chaudhry, Samaira Younis, Ina Nørgaard, Christopher Kjaer Cullum, Thien Phu Do, Dagmar Beier, Faisal Mohammad Amin

Get full text

The Registry for Migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics by William Kristian Karlsson, Håkan Ashina, Christopher Kjær Cullum, Rune Häckert Christensen, Haidar Muhsen Al-Khazali, Faisal Mohammad Amin, Messoud Ashina, on behalf of the REFORM Investigators

Get full text

Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study by Christopher Kjaer Cullum, Thien Phu Do, Messoud Ashina, Lars Bendtsen, Sarah Sonja Hugger, Afrim Iljazi, Julia Gusatovic, Josefin Snellman, Cristina Lopez-Lopez, Håkan Ashina, Faisal Mohammad Amin

Get full text

Use of Non-pharmacological Therapies in Individuals With Migraine Eligible for Treatment With Monoclonal Antibodies Targeting Calcitonin Gene-Related Peptide (CGRP)-Signaling: A Si... by Lucas Rundblad, Christopher Kjaer Cullum, Simona Sacco, Raquel Gil-Gouveia, Raquel Gil-Gouveia, Derya Uludüz, Thien Phu Do, Thien Phu Do, Faisal Mohammad Amin, Faisal Mohammad Amin

Get full text